Problems come joined at the hip with opportunities. Thermo Fisher Scientific (NYSE:TMO) has definitely found that to be the case with the COVID-19 pandemic. The company's growth has accelerated and its stock has soared over the last 12 months thanks primarily to coronavirus testing.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,